Jared L. Crandon

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

Anthony M. Nicasio, Robert E. Ariano, Sheryl Zelenitsky et al. · Antimicrobial Agents and Chemotherapy · 2009 · 121 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Clinical Pharmacodynamics of Cefepime in Patients Infected with <i>Pseudomonas aeruginosa</i>

Jared L. Crandon, Catharine C. Bulik, Joseph L. Kuti et al. · Antimicrobial Agents and Chemotherapy · 2009 · 120 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Comparative <i>In Vitro</i> and <i>In Vivo</i> Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Jared L. Crandon, Virna Schuck, Mary Anné Banevicius et al. · Antimicrobial Agents and Chemotherapy · 2012 · 115 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +11

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Andrew P. Tomaras, Jared L. Crandon, Craig J. McPherson et al. · Antimicrobial Agents and Chemotherapy · 2013 · 110 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers

Jared L. Crandon, David P. Nicolau · Antimicrobial Agents and Chemotherapy · 2013 · 105 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17